NO20002439D0 - New oral dosage forms for carvediol - Google Patents

New oral dosage forms for carvediol

Info

Publication number: NO20002439D0
Authority: NO; Norway
Prior art keywords: carvediol; dosage forms; oral dosage; new oral; new
Prior art date: 1997-11-12

Application number

NO20002439A

Other languages

Norwegian (no)

Other versions

NO20002439L (en

Inventor

Choon K Oh

Original Assignee

Boehringer Mannheim Pharm Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-12

Filing date

2000-05-11

Publication date

2000-05-11

2000-05-11 Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp

2000-05-11 Publication of NO20002439D0 publication Critical patent/NO20002439D0/en

2000-05-11 Publication of NO20002439L publication Critical patent/NO20002439L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)

NO20002439A 1997-11-12 2000-05-11 New oral dosage forms for carvediol NO20002439L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6545697P	1997-11-12	1997-11-12
PCT/US1998/024102 WO1999024017A1 (en)	1997-11-12	1998-11-12	Novel oral dosage form for carvedilol

Publications (2)

Publication Number	Publication Date
NO20002439D0 true NO20002439D0 (en)	2000-05-11
NO20002439L NO20002439L (en)	2000-05-11

Family

ID=22062830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20002439A NO20002439L (en)	1997-11-12	2000-05-11	New oral dosage forms for carvediol

Country Status (14)

Country	Link
EP (1)	EP1030651A4 (en)
JP (1)	JP2001522794A (en)
KR (1)	KR20010031952A (en)
CN (1)	CN1285738A (en)
AU (1)	AU751117B2 (en)
BR (1)	BR9814127A (en)
CA (1)	CA2309542A1 (en)
HU (1)	HUP0004345A3 (en)
IL (1)	IL136028A0 (en)
NO (1)	NO20002439L (en)
NZ (1)	NZ504418A (en)
PL (1)	PL340456A1 (en)
TR (1)	TR200001362T2 (en)
WO (1)	WO1999024017A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040151772A1 (en)	2002-11-08	2004-08-05	Egalet A/S	Controlled release carvedilol compositions
WO2004056336A2 (en) *	2002-12-20	2004-07-08	Ranbaxy Laboratories Limited	Controlled release, multiple unit drug delivery systems
JP2007512350A (en) *	2003-11-25	2007-05-17	エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド	Carvedilol composition treatment and delivery methods
WO2005051322A2 (en)	2003-11-25	2005-06-09	Sb Pharmco Puerto Rico Inc.	Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
EP2010162A4 (en) *	2006-04-03	2013-01-09	Isa Odidi	Drug delivery composition
TWI415604B (en) *	2009-09-29	2013-11-21	Tsh Biopharm Corp Ltd	Regulated release of caffetilol dosage form
JP5749247B2 (en) *	2010-02-22	2015-07-15	第一三共株式会社	Oral sustained-release solid preparation
ES2600894T3 (en) *	2010-02-22	2017-02-13	Daiichi Sankyo Company, Limited	Solid sustained release preparation for oral use
EP2540317A4 (en) *	2010-02-22	2014-04-16	Daiichi Sankyo Co Ltd	SOLID RELEASE PREPARATION FOR ORAL USE
BR112015004190A2 (en)	2012-09-03	2017-07-04	Daiichi Sankyo Co Ltd	sustained release pharmaceutical composition, and method for producing a sustained release pharmaceutical composition
KR102158339B1 (en) *	2016-02-05	2020-09-21	삼진제약주식회사	Carvedilol immediate release formulation having improved madescent
KR102492147B1 (en)	2020-12-30	2023-01-26	단국대학교 천안캠퍼스 산학협력단	Carvedilol loaded solid oral compositions using self-nanoemulsifying drug delivery system and methods for their preparation
KR102525298B1 (en)	2020-12-30	2023-04-25	단국대학교 천안캠퍼스 산학협력단	Carvedilol loaded solid dispersion with increased oral bioavailability and methods for their preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2815926A1 (en) *	1978-04-13	1979-10-18	Boehringer Mannheim Gmbh	NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
JPS5598120A (en) *	1979-01-16	1980-07-25	Shin Etsu Chem Co Ltd	Preparation of drug having enteric coating
CA1146866A (en) *	1979-07-05	1983-05-24	Yamanouchi Pharmaceutical Co. Ltd.	Process for the production of sustained release pharmaceutical composition of solid medical material
US4680323A (en) *	1983-12-01	1987-07-14	Hans Lowey	Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
AU641065B2 (en) *	1990-10-23	1993-09-09	Davband Pty. Limited	Back support for a chair or seat
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
DE19637082A1 (en) *	1996-09-12	1998-03-19	Boehringer Mannheim Gmbh	Rapidly disintegrating pellets

1998
- 1998-11-12 CN CN98813082A patent/CN1285738A/en active Pending
- 1998-11-12 JP JP2000520110A patent/JP2001522794A/en active Pending
- 1998-11-12 WO PCT/US1998/024102 patent/WO1999024017A1/en not_active Ceased
- 1998-11-12 NZ NZ504418A patent/NZ504418A/en unknown
- 1998-11-12 AU AU14569/99A patent/AU751117B2/en not_active Ceased
- 1998-11-12 BR BR9814127-9A patent/BR9814127A/en not_active IP Right Cessation
- 1998-11-12 HU HU0004345A patent/HUP0004345A3/en unknown
- 1998-11-12 IL IL13602898A patent/IL136028A0/en not_active IP Right Cessation
- 1998-11-12 EP EP98958546A patent/EP1030651A4/en not_active Withdrawn
- 1998-11-12 PL PL98340456A patent/PL340456A1/en unknown
- 1998-11-12 KR KR1020007005059A patent/KR20010031952A/en not_active Ceased
- 1998-11-12 CA CA002309542A patent/CA2309542A1/en not_active Abandoned
- 1998-11-12 TR TR2000/01362T patent/TR200001362T2/en unknown
2000
- 2000-05-11 NO NO20002439A patent/NO20002439L/en unknown

Also Published As

Publication number	Publication date
WO1999024017A1 (en)	1999-05-20
EP1030651A1 (en)	2000-08-30
AU751117B2 (en)	2002-08-08
NZ504418A (en)	2003-02-28
IL136028A0 (en)	2001-05-20
NO20002439L (en)	2000-05-11
CA2309542A1 (en)	1999-05-20
AU1456999A (en)	1999-05-31
EP1030651A4 (en)	2006-05-31
TR200001362T2 (en)	2000-09-21
JP2001522794A (en)	2001-11-20
HUP0004345A3 (en)	2001-10-29
CN1285738A (en)	2001-02-28
HUP0004345A2 (en)	2001-06-28
PL340456A1 (en)	2001-02-12
KR20010031952A (en)	2001-04-16
BR9814127A (en)	2000-10-03

Publication	Publication Date	Title
ATE371449T1 (en)	2007-09-15	SOLID ORAL DOSAGE FORMS CONTAINING VALSARTAN
DE69928777D1 (en)	2006-01-12	DOSAGE DISPENSER
NO20005832L (en)	2001-01-18	New special formulations
DE69704965D1 (en)	2001-07-05	Dosage dispenser
EE200000383A (en)	2001-12-17	Oral pharmaceutical extended release dosage form
DE60038698D1 (en)	2008-06-05	HYDROGEL-CONTROLLED DOSAGE FORM
NO20003640D0 (en)	2000-07-14	New dosage form
ATE321483T1 (en)	2006-04-15	CAN
DK0754061T3 (en)	2002-08-26	New oral pharmaceutical dosage form
IS4886A (en)	1998-11-06	Dosage unit for unit dose
EE9800194A (en)	1998-12-15	New analgesic compounds
DK1043977T3 (en)	2004-02-09	Oral pharmaceutical dosage form based on pulsed release
DE59506139D1 (en)	1999-07-15	Oral sustained-release preparation
NO992339L (en)	1999-11-16	Pharmaceutical Formulations
NO992692D0 (en)	1999-06-03	Nefadozone dosage form
DE59712959D1 (en)	2008-09-25	ORAL PHARMACEUTICAL PREPARATION CONTAINING IBANDRONAT
NO20001938D0 (en)	2000-04-13	New aryloxy-alkyl-dialkylamines
NO20005210D0 (en)	2000-10-17	Dosage device for removable media
DE60007530D1 (en)	2004-02-05	ORAL EFFECTIVE ANDROGENE
NO20002439L (en)	2000-05-11	New oral dosage forms for carvediol
FI962989A7 (en)	1996-07-26	Fast-dissolving oral dosage form
NO20014926L (en)	2001-12-13	Pharmaceutical compounds
ID30032A (en)	2001-11-01	PHARMACEUTICAL FORMULATION
NO20023190D0 (en)	2002-07-01	Oral mucosal dosage forms for apomorphine
FI964918L (en)	1997-02-07	Pharmaceutical salts